Calyxo says 789-patient REASON study shows 97% stone clearance for CVAC kidney stone system

  • Calyxo highlighted results already presented at the AUA 2026 meeting on its CVAC kidney stone treatment system.
  • A large retrospective, multicenter real-world analysis found the system delivered strong stone removal with a low rate of complications.
  • A separate multicenter comparison indicated performance held up in more complex cases versus suction-sheath approaches.
  • Benchtop testing also showed quicker fragment clearance than direct-in-scope suction, supporting procedural efficiency claims.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Calyxo Inc. published the original content used to generate this news brief on May 27, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.